| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 06/29/2005 | CN1208319C 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 06/29/2005 | CN1208087C Method and compositions useful for modulation of angiogenesis using protein kinase Raf and Ras |
| 06/29/2005 | CN1208067C Powder medicine for treating otitis media and preparation method thereof |
| 06/28/2005 | US6911543 Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease |
| 06/28/2005 | US6911542 Pyrazino[1′,2′:1,6]pyrido[3,4b]indole derivatives |
| 06/28/2005 | US6911461 For treating epilepsy, epileptogenesis, seizure disorders, convulsions, bipolar disorders, mania, depression, anxiety, migraine, neuralgia, chronic pain, neuropathic pain, cerebral ischemia, cardiac arrhythmia, myotonia, cocaine abuse |
| 06/28/2005 | US6911444 Non-steroidal IL-5 inhibitors, processes and intermediates for their preparation and pharmaceutical compositions comprising said inhibitors |
| 06/28/2005 | US6911443 Imidazopyrimidine derivatives and triazolopyrimidine derivatives |
| 06/28/2005 | US6911440 For the treatment of inflammatory rheumatic/rheumatoid diseases and/or pain, rheumatoid arthritis |
| 06/28/2005 | US6911439 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents |
| 06/28/2005 | CA2168097C Substituted 2-aminotetralins |
| 06/23/2005 | WO2005056113A1 Compounds for the treatment of ocular dryness caused by photorefractive surgery |
| 06/23/2005 | WO2005039574A8 Therapeutic agent for keratoconjunctive disorder |
| 06/23/2005 | WO2005000406A3 Treatment of amyloid- and epileptogenesis-associated diseases |
| 06/23/2005 | US20050137167 Inhibiting FGF growth factor with heparins; antitumor agents; angiogenesis inhibitor; antidiabetic agent treating diabetic retinopathy; antiinflammatory agent; treating retrolenticular fibroplasia, psoriasis, restenosis after angioplasty and after coronary by-pass; chemical intermediates; drug delivery |
| 06/23/2005 | US20050137158 Methods for targeting RNA molecules |
| 06/23/2005 | US20050137148 treating an infectious disease associated with narrowing or obstruction of a body passageway by delivering to an external portion of the body passageway an antibiotic; infections such as pelvic inflammatory disease, urethritis, or tuberculosis |
| 06/23/2005 | US20050136133 Administering an anti-allergy composition of a wood-vinegar distilled solution, colorless and transparent |
| 06/23/2005 | CA2549161A1 Prevention and/or reduction of photoreceptor degeneration with retinoids |
| 06/23/2005 | CA2548446A1 Compounds for the treatment of dryness of the ocular surface caused by photorefractive surgery |
| 06/23/2005 | CA2546053A1 Amelioration of cataracts, macular degeneration and other ophthalmic diseases |
| 06/22/2005 | EP1544299A1 Modified chimeric polypeptides with improved pharmacokinetic properties |
| 06/22/2005 | EP1544281A1 Fat composition |
| 06/22/2005 | EP1544198A1 A process for the preparation of crystalline losartan potassium |
| 06/22/2005 | EP1543833A1 Phosphorylated dextran |
| 06/22/2005 | EP1543034A2 Treatment and prophylaxis with 4-1bb-binding agents |
| 06/22/2005 | EP1543024A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 06/22/2005 | EP1543003A2 Imidazo[1,2-a]pyridines |
| 06/22/2005 | EP1542984A2 Methods of purifying cannabinoids from plant material |
| 06/22/2005 | EP1542980A1 5-aryltetrazole compounds, compositions thereof, and uses therefor |
| 06/22/2005 | EP1542972A2 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use |
| 06/22/2005 | EP1542948A2 Novel biphenyl and biphenyl-like cannabinoids |
| 06/22/2005 | EP1542768A1 Use of cytokine synthesis inhibitors for the treatment of dry eye disorders |
| 06/22/2005 | EP1542716A1 Growth hormone releasing peptides |
| 06/22/2005 | EP1542692A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 06/22/2005 | EP1542686A2 Aryl substituted hydantoin compounds and their use as sodium channel blockers |
| 06/22/2005 | EP1542664A2 Methods and compositions for treatment of macular and retinal disease |
| 06/22/2005 | EP1542628A1 Medicinal product packaging |
| 06/22/2005 | EP1542536A2 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
| 06/22/2005 | EP1469856A4 8-heteroaryl xanthine adenosine a sb 2b /sb receptor antagonists |
| 06/22/2005 | EP1372656B1 Pyrazolo[4,3-d]pyrimidinone compounds as cgmp pde inhibitors |
| 06/22/2005 | EP1345933B1 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 06/22/2005 | EP1320523B1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 06/22/2005 | EP1305057B1 Microparticulate biomaterial composition of hyaluronic acid for medical use |
| 06/22/2005 | EP1272200B1 Divided dose therapies with vascular damaging activity |
| 06/22/2005 | EP1173201B1 Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 06/22/2005 | EP1154774B1 Quinazoline derivatives as angiogenesis inhibitors |
| 06/22/2005 | EP1040111B1 Integrin receptor antagonists |
| 06/22/2005 | CN1630709A Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 06/22/2005 | CN1630664A Caspase-8 binding protein, its preparation and use |
| 06/22/2005 | CN1630650A Nitrogenous heterocyclic compound and medicine thereof |
| 06/22/2005 | CN1630637A Novel arylheteroalkylamine derivatives |
| 06/22/2005 | CN1630633A N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
| 06/22/2005 | CN1630526A Systems and methods for treating patients with processed lipoaspirate cells |
| 06/22/2005 | CN1630515A Compounds active at the glucocorticoid receptor II |
| 06/22/2005 | CN1630512A Pharmaceutical tablet |
| 06/22/2005 | CN1630497A Drug delivery device |
| 06/22/2005 | CN1628783A Oral liquor containing creeping oxalis, zedoary and dahurian angelica and its preparing method |
| 06/22/2005 | CN1628759A Chinese medicinal formulation for treating asthenopia syndrome and its preparation method |
| 06/22/2005 | CN1628705A Eye drop and its preparation |
| 06/22/2005 | CN1628695A Eye lotion containing hyaluronic acid and hyaluronic salt and method for making same |
| 06/22/2005 | CN1206988C Eye gel for atropine sulfate |
| 06/22/2005 | CN1206987C Indomethacin liposome eye drops |
| 06/21/2005 | US6908943 Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of disease |
| 06/21/2005 | US6908920 Pyrimidine derivatives |
| 06/21/2005 | CA2250372C 6-phenylpyridyl-2-amine derivatives |
| 06/21/2005 | CA2180010C 7-¬carboxyalkyl or alkenyl|-6-¬alkyl or alkenyl| 3-oxo-2,4-dioxobicyclo-¬3.2.1| octane and derivatives thereof |
| 06/16/2005 | US20050132428 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 06/16/2005 | US20050131061 Angiogenesis inhibitors |
| 06/16/2005 | US20050131047 cardiovascular disorders |
| 06/16/2005 | US20050131040 Reacting losartan and poltassium compound in presence of water and aprotic solvent; salt formation |
| 06/16/2005 | US20050131032 (Oxime)carbamoyl fatty acid amide hydrolase inhibitors |
| 06/16/2005 | US20050131009 Urea substituted imidazoquinolines |
| 06/16/2005 | US20050131000 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity |
| 06/16/2005 | US20050130998 Central nervous ystem diorders; Alzheimer's disease ; anticancer agents |
| 06/16/2005 | US20050130967 3-Substituted-4-pyrimidone derivatives |
| 06/16/2005 | US20050130948 Therapeutic methods and uses of sapogenins and their derivatives |
| 06/16/2005 | US20050130930 Adenosine derivatives and use thereof |
| 06/16/2005 | US20050130903 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 06/16/2005 | US20050130902 Upregulate expression of a gene encoding an antioxidative anzyme, such as superoxide dismutase or catalase; neurodegenerative, cardiovascular, cerebral, disorders, trauma, injuries, burns, cancer |
| 06/16/2005 | US20050130881 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals |
| 06/16/2005 | US20050130304 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 06/16/2005 | US20050129736 Compositions and methods for treating or preventing diseases of body passageways |
| 06/16/2005 | US20050129665 Isolated lineage negative hematopoietic stem cells and methods of treatment therewith |
| 06/16/2005 | CA2547887A1 Protein modifier production inhibitor |
| 06/16/2005 | CA2547780A1 Antisense compounds targeted to connexins and methods of use thereof |
| 06/15/2005 | EP1541574A1 Triazaspiro 5.5 undecane derivatives and drugs comprisi ng the same as the active ingredient |
| 06/15/2005 | EP1541573A1 Novel crystals of triazaspiro 5.5 undecane derivative |
| 06/15/2005 | EP1541570A1 Novel physiologically active substance |
| 06/15/2005 | EP1541563A1 Ccr4 antagonist and medicinal use thereof |
| 06/15/2005 | EP1541559A1 5-substituted isoquinoline derivative |
| 06/15/2005 | EP1541151A1 REMEDY FOR GLAUCOMA COMPRISING Rho KINASE INHIBITOR AND PROSTAGLANDINS |
| 06/15/2005 | EP1541125A1 Spreadable compositions for topical use, a process of making same and uses thereof |
| 06/15/2005 | EP1539933A2 Methods of organ regeneration |
| 06/15/2005 | EP1539769A1 Bicyclic heteroaromatic compounds as kinase inhibitors |
| 06/15/2005 | EP1539763A1 Azaindole kinase inhibitors |
| 06/15/2005 | EP1539748A1 2-phenylpyridin-4-yl derivatives as alk5 inhibitors |
| 06/15/2005 | EP1539742A1 Indole derivatives useful as histamine h3 antagonists |
| 06/15/2005 | EP1539739A1 Piperidinyl compounds that selectively bind integrins |
| 06/15/2005 | EP1539732A1 Novel compounds |